James H. Litinsky, Director, Chairman and Chief Executive Officer, on May 12, 2026, sold 300,000 shares in Mp Materials (MP) for $19,634,359. Following the Form 4 filing with the SEC, Litinsky has control over a total of 12,422,362 common shares of the company, with 216,397 shares held directly and 12,205,965 controlled indirectly.
SEC Filing:
Joshua D. Frank, 10% Owner, Director, on May 12, 2026, sold 6,213,418 shares in Janus Henderson Group (JHG) for $320,612,990. Following the Form 4 filing with the SEC, Frank has control over a total of 25,654,382 common shares of the company, with 25,654,382 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1274173/000119312526224632/xslF345X05/ownership.xml
Antonio J Viana, Director, on May 13, 2026, sold 40,000 shares in Arteris (AIP) for $1,446,963. Following the Form 4 filing with the SEC, Viana has control over a total of 85,460 common shares of the company, with 20,840 shares held directly and 64,620 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1667011/000188868626000004/xslF345X05/primarydocument.xml
Martine A Rothblatt, Director, Chairperson & CEO, on May 13, 2026, sold 9,500 shares in United Therapeutics (UTHR) for $5,497,166. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 679,797 common shares of the company, with 40,513 shares held directly and 639,284 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1082554/000110657826000053/xslF345X05/primarydocument.xml